024sek
0,0 %
Date:2024-07-24Time:17:29:00Latest report:Q1-2024List:First NorthTicker:IZAFE B
Market Cap:65 msekEnterprise Value:67 msekNet Sales:5,00 msekEarnings:-32,8 msekEmployees:0ISIN:SE0003656834

Ratios

10-year key figure history for iZafe turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for iZafe with index and moving average MA50 and MA200.

Stockprice:0,24
MA50:0,23
MA200:0,26
Price/MA200:-9,8 %
RSI (14):54,5
Price/MA50:2,8 %

Description

iZafe Group AB is a pure Life-Science company engaged in the development of digital drug dispensing. The company conducts research, development and marketing of digital medical solutions and services for safer drug management at home. iZafe's drug robot Dosell is used to reduce the risk of incorrect medication at home, relieve public care, increase the patient's quality of life and create a safer environment for relatives. The customers consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe sells through well-established partners who already have long and deep customer relationships with the priority customer groups.

Medical Equipment